Auxly Cannabis Group Inc XLY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if XLY is a good fit for your portfolio.
News
-
AUXLY ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
-
AUXLY ANNOUNCES ANNUAL GENERAL MEETING OF SHAREHOLDERS
-
AUXLY REPORTS RECORD FIRST QUARTER 2024 FINANCIAL RESULTS
-
AUXLY TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 13, 2024
-
AUXLY ANNOUNCES EXPANSION INTO QUEBEC AND LAUNCHES NEW TRANSFORMATIVE PRE-ROLL AND VAPE INNOVATION
-
Organigram's stock soars as British American Tobacco invests $91.3 million
Trading Information
- Previous Close Price
- CAD 0.03
- Day Range
- CAD 0.03–0.03
- 52-Week Range
- CAD 0.01–0.07
- Bid/Ask
- CAD 0.03 / CAD 0.03
- Market Cap
- CAD 37.59 Mil
- Volume/Avg
- 304,008 / 620,758
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.30
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company's focus is on developing, manufacturing, and distributing branded cannabis products. The group activities operate through two segments which include Canadian Cannabis operations, and South American Cannabis operations.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 369
- Website
- https://www.auxly.com
Valuation
|
Metric
|
XLY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.93 |
Price/Sales | 0.30 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
XLY
|
|---|---|
Quick Ratio | 0.35 |
Current Ratio | 0.73 |
Interest Coverage | −0.79 |
Quick Ratio
XLY
Profitability
|
Metric
|
XLY
|
|---|---|
Return on Assets (Normalized) | −18.38% |
Return on Equity (Normalized) | −699.89% |
Return on Invested Capital (Normalized) | −16.22% |
Return on Assets
XLY
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Fzbvytkmc | Wvnz | $79.8 Bil | |||
| Merck KGaA ADR
MKKGY
| Ghnvcxvhsv | Lrkspv | $71.7 Bil | |||
| Haleon PLC ADR
HLN
| Xxfmsszdt | Lgw | $37.5 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Ddcptqbl | Vxkn | $13.0 Bil | |||
| Viatris Inc
VTRS
| Htjxnxyj | Lnky | $12.3 Bil | |||
| Catalent Inc
CTLT
| Hmmyngxn | Nksrpv | $10.3 Bil | |||
| Perrigo Co PLC
PRGO
| Bjdxyxk | Cng | $3.5 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Kjqbpmqnt | Hkyrkxx | $3.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Tsvnvfyv | Lvtt | $2.8 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Pbyftqlvd | Dtyvb | $2.7 Bil |